NLRP3 might promote MPN development through several mechanism, including maturation of IL-1β and IL-18, initiation of pyroptosis by cleaving the pore-forming cell death executor gasdermin D and degradation of the hematopoietic lineage specifying transcription factor GATA1. Here, GATA1 is linked to myeloproliferative disorder.